(Q44448589)

3 December 2017

Elevated vitamin D status in postmenopausal women on thiazolidinediones for type 2 diabetes (English)

1 reference

3 December 2017

0 references

1 reference

Somchodok Chakreeyarat

1

1 reference

3 December 2017

Sunee Saetung

2

1 reference

3 December 2017

La-or Chailurkit

3

1 reference

3 December 2017

Sasivimol Rattanasiri

4

1 reference

3 December 2017

Suparat Ditbanjong

5

1 reference

3 December 2017

Niyata Chitrapazt

6

1 reference

3 December 2017

Supaneewan Jaovisidha

7

1 reference

3 December 2017

Boonsong Ongphiphadhanakul

8

1 reference

3 December 2017

11 November 2010

1 reference

3 December 2017

1 reference

3 December 2017

39

1 reference

3 December 2017

3

1 reference

3 December 2017

278-282

1 reference

https://scigraph.springernature.com/pub.10.1007/s12020-010-9426-1

3 December 2017

0 references

cites work

Thiazolidinedione use and bone loss in older diabetic adults

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9426-1

Diabetes, TZDs, and Bone: A Review of the Clinical Evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9426-1

Asymptomatic vertebral deformity as a major risk factor for subsequent fractures and mortality: a long-term prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9426-1

Vertebral fractures in males with type 2 diabetes treated with rosiglitazone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9426-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9426-1

Vertebral fracture assessment using a semiquantitative technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9426-1

Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9426-1

Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9426-1

Thiazolidinediones and fractures in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9426-1

Use of thiazolidinediones and fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9426-1

Association of plasma vitamin D levels with adiposity in Hispanic and African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9426-1

Relation of body fat indexes to vitamin D status and deficiency among obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9426-1

Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9426-1

25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9426-1

Vitamin D3 distribution and status in the body

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9426-1

Association between serum 25-hydroxyvitamin D levels and body composition in postmenopausal women: the postmenopausal Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9426-1

Determinants of serum 25 hydroxyvitamin D levels in a nationwide cohort of blacks and non-Hispanic whites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9426-1

Regulation of human vitamin D(3) 25-hydroxylases in dermal fibroblasts and prostate cancer LNCaP cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9426-1

Rosiglitazone alleviates the persistent fibrotic phenotype of lesional skin scleroderma fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9426-1

Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9426-1

Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9426-1

Decreased bioavailability of vitamin D in obesity

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21069575

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Dermal fibroblasts pretreated with a sterol Delta7-reductase inhibitor produce 25-hydroxyvitamin D3 upon UVB irradiation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21069575

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12020-010-9426-1

1 reference

3 December 2017

1 reference